ATE409493T1 - Peptidzusammensetzungen zur behandlung periodontaler krankheiten und prävention der hautalterung - Google Patents

Peptidzusammensetzungen zur behandlung periodontaler krankheiten und prävention der hautalterung

Info

Publication number
ATE409493T1
ATE409493T1 AT01938424T AT01938424T ATE409493T1 AT E409493 T1 ATE409493 T1 AT E409493T1 AT 01938424 T AT01938424 T AT 01938424T AT 01938424 T AT01938424 T AT 01938424T AT E409493 T1 ATE409493 T1 AT E409493T1
Authority
AT
Austria
Prior art keywords
peptide
alpha
casein
prevention
treatment
Prior art date
Application number
AT01938424T
Other languages
English (en)
Inventor
John Smith
Original Assignee
Pepsyn Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pepsyn Ltd filed Critical Pepsyn Ltd
Application granted granted Critical
Publication of ATE409493T1 publication Critical patent/ATE409493T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Genetics & Genomics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
AT01938424T 2000-06-30 2001-06-13 Peptidzusammensetzungen zur behandlung periodontaler krankheiten und prävention der hautalterung ATE409493T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0016189.3A GB0016189D0 (en) 2000-06-30 2000-06-30 Cosmetic composition

Publications (1)

Publication Number Publication Date
ATE409493T1 true ATE409493T1 (de) 2008-10-15

Family

ID=9894839

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01938424T ATE409493T1 (de) 2000-06-30 2001-06-13 Peptidzusammensetzungen zur behandlung periodontaler krankheiten und prävention der hautalterung

Country Status (10)

Country Link
US (1) US7579315B2 (de)
EP (1) EP1317274B1 (de)
JP (1) JP2004501976A (de)
CN (1) CN100536911C (de)
AT (1) ATE409493T1 (de)
AU (2) AU6410201A (de)
CA (1) CA2412836A1 (de)
DE (1) DE60135996D1 (de)
GB (1) GB0016189D0 (de)
WO (1) WO2002002133A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0209384D0 (en) * 2002-04-24 2002-06-05 Pepsyn Ltd Peptide composition
AU2003299568B2 (en) * 2002-11-27 2010-07-22 Ampio Pharmaceuticals, Inc. Treatment of diseases and conditions mediated by increased phosphorylation
US20090143311A1 (en) * 2005-04-28 2009-06-04 Luppo Edens Compositions comprising tripeptides inhibiting ace
US20090304869A1 (en) * 2005-04-28 2009-12-10 Christianus Jacobus Van Platerink Peptides Having an Ace Inhibiting Effect
ES2319475B1 (es) * 2005-06-08 2010-02-16 Consejo Superior Investig. Cientificas Peptidos bioactivos identificados en hidrolizados enzimaticos de caseinas lacteas y procedimiento de obtencion.
GB0525958D0 (en) * 2005-12-20 2006-02-01 Ares Trading Sa Casein-like secreted protein
US20080311058A1 (en) * 2007-06-18 2008-12-18 Connopco, Inc., D/B/A Unilever Stable high internal phase emulsions and compositions comprising the same
EP2371375A4 (de) * 2008-12-15 2013-01-02 Calpis Co Ltd Peptide zur hemmung von hautalterung
US8821839B2 (en) 2010-10-22 2014-09-02 Conopco, Inc. Compositions and methods for imparting a sunless tan with a vicinal diamine
US8398959B2 (en) 2010-12-06 2013-03-19 Conopco, Inc. Compositions and methods for imparting a sunless tan with functionalized adjuvants
US8961942B2 (en) 2011-12-13 2015-02-24 Conopco, Inc. Sunless tanning compositions with adjuvants comprising sulfur comprising moieties
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
JP6739730B2 (ja) * 2016-12-15 2020-08-12 株式会社田中造園土木 皮膚および骨の活性化を促進するための医薬組成物およびその製造方法
CN119320440B (zh) * 2023-07-06 2026-03-17 中国科学院大连化学物理研究所 一种抗菌肽及其应用
CN117964692B (zh) * 2024-02-04 2024-11-29 杭州康源食品科技有限公司 一种具有助睡眠活性的五肽及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558770A (en) * 1967-09-01 1971-01-26 Kraftco Corp Wound treating composition employing an enzyme modified casein
US5086164A (en) * 1989-01-10 1992-02-04 Repligen Corporation Novel methods and compositions for treatment of angiogenic diseases
JPH03255095A (ja) * 1990-03-02 1991-11-13 Kanebo Ltd カゼインペプチド
FR2673374A1 (fr) * 1991-03-01 1992-09-04 Oreal Composition cosmetique contenant comme ingredient actif un peptide a activite opiouide.
JPH06211689A (ja) * 1993-01-19 1994-08-02 Kanebo Ltd 鎮静剤及び精神安定用食品
US5965536A (en) * 1993-12-15 1999-10-12 Board Of Regents, The University Of Texas System Methods of inhibiting CXC intercrine molecules
US6241753B1 (en) * 1995-05-05 2001-06-05 Thermage, Inc. Method for scar collagen formation and contraction
US5851522A (en) * 1995-06-07 1998-12-22 Trustees Of Tufts College Enhancing keratinocyte migration
GB9522302D0 (en) * 1995-10-31 1996-01-03 Univ Liverpool Growth promoters
CA2296311A1 (en) * 1999-01-28 2000-07-28 Universite Laval Enzymatic hydrolysate of milk proteins

Also Published As

Publication number Publication date
CA2412836A1 (en) 2002-01-10
JP2004501976A (ja) 2004-01-22
AU2001264102B2 (en) 2007-01-11
WO2002002133A2 (en) 2002-01-10
CN100536911C (zh) 2009-09-09
EP1317274A2 (de) 2003-06-11
WO2002002133A3 (en) 2002-10-17
DE60135996D1 (de) 2008-11-13
US20040014653A1 (en) 2004-01-22
EP1317274B1 (de) 2008-10-01
GB0016189D0 (en) 2000-08-23
AU6410201A (en) 2002-01-14
CN1438895A (zh) 2003-08-27
US7579315B2 (en) 2009-08-25

Similar Documents

Publication Publication Date Title
ATE409493T1 (de) Peptidzusammensetzungen zur behandlung periodontaler krankheiten und prävention der hautalterung
ATE450269T1 (de) Peptid pyyä3-36ü zur behandlung von stoffwechselkrankheiten
HUP0100627A1 (hu) Amiloidogén betegségek megelőzése és kezelése
ATE208212T1 (de) Gel zur behandlung von hauterkrankungen und zur desinfizierung von haut
RU2008136324A (ru) Желудочно-кишечный пролиферативный фактор и его применения
ATE285219T1 (de) Rekombinante haarbehandlungsmittel
NZ512866A (en) A nutritional composition comprising at least one tolerogenic peptide, selected for its ability to induce oral tolerance, as an active ingredient
DE60128540D1 (de) Verwendung von relaxin zur behandlung von durch gefässverengung bedingten erkrankungen
WO2003039454A3 (en) Beta-secretase inhibitors and methods of use
ATE390928T1 (de) Zusammensetzungen zur behandlung von hauterkrankungen
DE59811158D1 (de) Verwendung von erythropoietin und eisenpräparaten zur herstellung von pharmazeutischen kombinationspräparaten zur behandlung von rheumatischen erkrankungen
DE69934813D1 (de) Verwendung von gaba analogen zur herstellung eines arzneimittels zur behandlung von manie und bipolaren erkrankungen
SE0002202D0 (sv) New peptides
ATE497390T1 (de) Neue therapeutische verwendung von smr-1 peptide
ATE399002T1 (de) Pharmazeutische zubereitungen für die behandlung von läsionen der haut und schleimhäute und diese verwendende verfahren und kits
ATE177646T1 (de) Protein präparate zur verhütung und behandlung van periodontitis und sonstigen bakteriellen erkrankungen der mundhöhle
DE69420145D1 (de) Behandlung präkanzeröser läsionen durch muramylpeptide
JP2004527452A5 (de)
DE69939075D1 (de) Pharmazeutische Zusammenstellung zur Vorbeugung und Behandlung von mit Zellkrankheiten des Augenhintergrundes zusammenhängenden Krankheiten
ES2135398T3 (es) Compuesto y composiciones de inhibicion de la resorcion osea.
YU45103A (sh) Upotreba sarp/1 za lečenje i prevenciju skleroderme
EP1940872A4 (de) Peptide, die bei der linderung von hautleiden oder der behandlung von periodentalkrankheiten wirkung zeigen
ATE371737T1 (de) Proteaseresistente flint-analoge
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
EP1243595A4 (de) Mit bh4 fusionierte polypeptide

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties